Avecho Biotechnology Limited (ASX:AVE) was featured in Stockhead’s Top 10 at 10, following the announcement of results from our Phase 1 PK study characterising the absorption of cannabidiol from our CBD soft gel capsule.
Read the article here.
August 25, 2021August 25, 2021
May 5, 2022May 5, 2022
January 19, 2021February 23, 2021
Your email address will not be published.Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Sign me up for the newsletter!